Why Do Securities Class Actions Drag on Once SCOTUS Gets Involved?
When Connecticut State Treasurer Denise Nappier announced Wednesday that the state retirement fund, as the lead plaintiff in a securities class action against the biotech company Amgen, had settled the case for $95 million, I was startled to realize the litigation was still going on. It’s been a while, after all. Investors first sued Amgen all the way back in 2007 for (among other …